Interventional therapy in resistant hypertension; new renal denervation applications in Turkey

References (1)

1. Kearney PM, Whelton M, Reynolds K, Muntner P Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-23. [CrossRef] 2. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9. [CrossRef] 3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13. [CrossRef] 4. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117: e510-26. [CrossRef] 5. Persell SD. Prevalence of resistant hypertension in the United States, 2003- 2008. Hypertension 2011; 57: 1076-80. [CrossRef] 6. Schlaich MP Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009; 54: 1195-201. [CrossRef] 7. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary D. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens 2004; 17: 217-22. [CrossRef] 8. Schlaich MP Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009; 361: 932-4. [CrossRef] 9. Symplicity HTN-1 Investigators. Krum H, Barman N, Schlaich M, Sobotka P Esler M, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911-7. [CrossRef] 10. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP Schmieder RE, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomi- zed controlled trial. Lancet 2010; 376: 1903-9. [CrossRef]